Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Revenue	$ 104,573	$ 47,152
Costs and expenses
Cost of revenue	57,350	11,813
Research and development	2,889,253	2,106,910
General and administrative	4,099,741	3,143,462
Total costs and expenses	7,046,344	5,262,185
Loss from operations	(6,941,771)	(5,215,033)
Other income, net
Interest income, net	22,070	74,819
Change in fair value of warrant liabilities		1,136,677
Other income, net	432,942	91,890
Total other income, net	455,012	1,303,386
Net loss	$ (6,486,759)	$ (3,911,647)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.59)	$ (3.4)
Net loss per share attributable to common stockholders, diluted (in Dollars per share)	$ (0.59)	$ (3.4)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	11,008,586	1,150,882
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares)	11,008,586	1,150,882